Technical Innovations for Deploying Implantation of an Implanted Continuous Glucose Monitor [0.03%]
植入式连续葡萄糖监测仪的技术创新及置入方法
Baudolino Mussa,Mariagrazia Tammaro,Barbara Defrancisco
Baudolino Mussa
Applications of Artificial Intelligence and Machine Learning in Prediabetes: A Scoping Review [0.03%]
人工智能和机器学习在糖尿病前期的应用：综述研究
Benjamin Lalani,Rohan Herur,Daniel Zade et al.
Benjamin Lalani et al.
Introduction: Prediabetes is a prevalent condition in which early detection and lifestyle interventions can prevent or delay progression to diabetes. Artificial intelligence (AI) and machine learning (ML) offer enhanced t...
Comparative Performance Analysis of Manual and Updated Optional Calibration Algorithms for the CareSens Air CGM System [0.03%]
手动和更新的可选校准算法的CareSens Air动态血糖监测系统性能比较分析
Nina Jendrike,Manuel Eichenlaub,Manuela Link et al.
Nina Jendrike et al.
Background: The CE-marked CareSens Air continuous glucose monitoring (CGM) system (CSAir) features a 15-day sensor lifetime, a 2-hour warm-up period and mandatory manual calibrations. During subsequent product development...
First in Human Feasibility Study: Automated Insulin Delivery Utilizing a Self-Adapting Algorithm in Adults With Type 1 and Type 2 Diabetes [0.03%]
人用首次可行性研究：利用自适应算法的自动胰岛素输送在1型和2型糖尿病成人中的应用
Tom Wilkinson,Solita Donnelly,Claire Lever et al.
Tom Wilkinson et al.
Background: This feasibility study assessed a novel self-adapting closed-loop system which does not require carbohydrate announcement, in adults with type 1 and type 2 diabetes. ...
Postpartum Continuous Glucose Monitoring to Detect Dysglycemia After Gestational Diabetes [0.03%]
用于筛查妊娠期糖尿病后血糖异常的产后持续葡萄糖监测
Camila Cabrera,Selassie Ogyaadu,Camilla Levister et al.
Camila Cabrera et al.
Background: Up to one-third of people with gestational diabetes (GDM) will have persistent dysglycemia, and more than half do not complete the recommended postpartum oral glucose tolerance test (OGTT). This study assessed...
Halis Kaan Akturk,Sue A Brown,Roy W Beck et al.
Halis Kaan Akturk et al.
Introduction: The Diabetes Control and Complications Trial (DCCT) clearly documented long-term beneficial effects on both micro- and macro-vascular complications associated with type 1 diabetes (T1D) by using intensive in...
Research Gaps, Challenges, and Opportunities in Automated Insulin Delivery Systems [0.03%]
自动化胰岛素输送系统的研究空白、挑战和机遇
Peter G Jacobs,Carol J Levy,Sue A Brown et al.
Peter G Jacobs et al.
Background: Since the discovery of the life-saving hormone insulin in 1921 by Dr Frederick Banting in 1921, there have been many critical discoveries and technical breakthroughs that have enabled people living with type 1...
Howard Zisser,Roman Hovorka,Ananda Basu et al.
Howard Zisser et al.
The development of automated insulin delivery systems has seen tremendous improvements from individual components to interoperable system combinations of devices and new drugs besides insulin. The components have become progressively smalle...
Francis J Doyle rd,Boris P Kovatchev
Francis J Doyle rd
Evolution of the Artificial Pancreas: Components and Integration-CGMs, Insulin, and AP Systems [0.03%]
人工胰腺的发展：组件和集成-持续葡萄糖监测系统，胰岛素和AP系统
Richard M Bergenstal,Adam Heller,Marc D Breton et al.
Richard M Bergenstal et al.
The landmark Diabetes Control and Complications Trial (DCCT) showed that glucose control is critical to reducing the risk of diabetes-related complications. This chapter outlines a series of innovations and investigations that followed the ...